These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 567282)

  • 41. Differences in the content and turnover of noradrenaline in rat heart atria and ventricles and circadian-phase-dependency.
    Lemmer B; Weimer R
    Experientia; 1983 Sep; 39(9):998-1000. PubMed ID: 6884497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The irritant properties of dopamine-beta-hydroxylase inhibitors in relation to their effects on L-dopa-induced locomotor activity.
    Dolphin A; Elliott PN; Jenner P
    J Pharm Pharmacol; 1976 Oct; 28(10):782-5. PubMed ID: 10378
    [No Abstract]   [Full Text] [Related]  

  • 43. Behavioral depression: thyroid interactions with norepinephrine-depleting drugs.
    Davenport JW; Hennies RS; Carey JC; Bishop SB
    Pharmacol Biochem Behav; 1976 Jul; 5(1):87-9. PubMed ID: 186817
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Very rapid turnover of dopamine in noradrenaline cell body regions.
    Andén NE; Grabowska-Andén M; Lindgren S; Oweling M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):258-63. PubMed ID: 4022136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of catecholamine synthesis inhibition on ethanol narcosis in mice.
    Blum K; Merritt JH; Wallace JE; Owen R; Hahn JW; Geller I
    Curr Ther Res Clin Exp; 1972 Jun; 14(6):324-9. PubMed ID: 4625804
    [No Abstract]   [Full Text] [Related]  

  • 46. Biosynthesis of catecholamines, uptake of 3H-noradrenaline, and reactivity of cardiovascular system of the rat after chronic and acute treatment with a new antidepressant agent, IPF C-45.
    Filczewski M; Szymańska-Kosmala M; Oledzka K
    Pol J Pharmacol Pharm; 1977; 29(1):23-9. PubMed ID: 854479
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of hypothalamic catecholamine synthesis inhibition by alpha-methyltyrosine on gonadotropin secretion during sexual maturation in the male Wistar rat.
    Raum WJ; Swerdloff RS
    Endocrinology; 1986 Jul; 119(1):168-75. PubMed ID: 2873025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of inhibition of catecholamine synthesis on central catecholamine-containing neurones in the developing albino rat.
    Loizou LA
    Br J Pharmacol; 1971 Jan; 41(1):41-8. PubMed ID: 5547761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 24-Hour changes in catecholamine synthesis in rat and hamster pineal glands.
    Craft CM; Morgan WW; Reiter RJ
    Neuroendocrinology; 1984 Mar; 38(3):193-8. PubMed ID: 6144062
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship between amphetamine antagonism and depletion of brain catecholamines by alpha-methyl-p-tyrosine in rats.
    Widerlöv E; Lewander T
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):125-34. PubMed ID: 703855
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Involvement of the brain catecholaminergic system in the regulation of dominant behavior.
    Serova LI; Naumenko EV
    Pharmacol Biochem Behav; 1996 Feb; 53(2):285-90. PubMed ID: 8808133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DL-threo-DOPS as a precursor of noradrenaline.
    Reches A; Jackson-Lewis V; Fahn S
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):202-8. PubMed ID: 3937060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
    Antelman SM; Szechtman H; Chin P; Fisher AE
    J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
    [No Abstract]   [Full Text] [Related]  

  • 54. Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnover.
    Snider SR; Hutt C; Stein B; Prasad AL; Fahn S
    J Pharm Pharmacol; 1976 Jul; 28(7):563-6. PubMed ID: 8610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
    Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
    Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanism of inhibition of dopamine beta-hydroxylase evoked by FLA-63. An in vitro study.
    Brodde OE; Nagel M; Schümann HJ
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):184-90. PubMed ID: 921409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Entrainment of the rat motor activity rhythm: effects of the light-dark cycle and physical exercise.
    Cambras T; Vilaplana J; Campuzano A; Canal-Corretger MM; Carulla M; Díez-Noguera A
    Physiol Behav; 2000; 70(3-4):227-32. PubMed ID: 11006420
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of dopaminergic agonists and antagonists of feeding in intact and 6-hydroxydopamine-treated rats.
    Heffner TG; Zigmond MJ; Stricker EM
    J Pharmacol Exp Ther; 1977 May; 201(2):386-99. PubMed ID: 859104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity rhythms and masking response in the diurnal fat sand rat under laboratory conditions.
    Barak O; Kronfeld-Schor N
    Chronobiol Int; 2013 Nov; 30(9):1123-34. PubMed ID: 23926956
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Further evidence for a change in central alpha-adrenergic receptor sensitivity after withdrawal from long-term haloperidol treatment.
    Dunstan R; Jackson DM
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jun; 303(2):153-6. PubMed ID: 209350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.